`
`lofl
`
`AACR Journals Online
`
`Beginning January 22, 2001 . the full text of all AACRjoumals will be available online through a. partnership
`with Highwire Press. Please explore the resources offered by the followingjournal sites:
`
`Obtain general information about all AACR publications and link to the AACR
`journal sites. Search across all AACR journals.
`
`Cancer Research Ogline. Access the 1999, 2000, and 2001 volumes in full-text, searchable SGML and in PDF
`format. Search the abstracts of every issue of thejournal dating back to the 1975 volume. [Please note: While
`the 2000 and 2001 volumes will be available in full~text SGML immediately upon launch, the 1999 volume
`will be available in early February]
`
`Clinical Cancer Research Online. Access the 1999, 2000, and 2001 volumes in full-text, searchable SGML and
`in PDF format. Search the abstracts of every issue of the journal dating back to the inaugural 1995 volume.
`[Please note: While the 2000 and 2001 volumes will be available in ful1—text SGML immediately upon launch.
`the 1999 volume will be available in early February]
`
`Access the 1999,2000, and 2001 volumes in full—text,
`searchable SGML and in PDF format. Search the abstracts of every issue of the journal dating back to the
`inaugural 1991 volume.
`
`Access the 1999, 2000, and 2001 volumes in full-text, searchable
`SGML and in PDF format. Search the abstracts of every issue of thejournal dating back to the inaugural 1990
`volume.
`
`After the launch of AACR Journals Online, thejoumal sites will be available to the public at no charge through
`the end of February. Beginning March 1, 2001, access to the full-text SGML and PDF versions of each journal
`will be limited to subscribers. However, access to the journal abstracts and the search features will continue to
`be available to the public at no charge.
`
`We encourage everyone to take advantage of this trial period to evaluate the resources offered by AACR
`Journals Online. To subscribe to an AACR journal, contact the AACR Subscription Office [Phone: (800)
`6334931 or (205) 995- 1567; Fax (205) 995- 1588].
`
`http:l/webarchiveorgfweb/20!}1 l 103045945lhttp:llwww.aacr.orgl2000/2100/2l00m_html
`
`Astrazeneca Ex. 2042 p. 1
`Mylan Pharms. Inc. V. Astrazeneca AB IPR2016-013 16